HK1214633A1 - 癌症的分子診斷測試 - Google Patents

癌症的分子診斷測試

Info

Publication number
HK1214633A1
HK1214633A1 HK16102633.1A HK16102633A HK1214633A1 HK 1214633 A1 HK1214633 A1 HK 1214633A1 HK 16102633 A HK16102633 A HK 16102633A HK 1214633 A1 HK1214633 A1 HK 1214633A1
Authority
HK
Hong Kong
Prior art keywords
cancer
diagnostic test
molecular diagnostic
molecular
test
Prior art date
Application number
HK16102633.1A
Other languages
English (en)
Inventor
Dennis Paul Harkin
Fionnuala Patterson
Claire Trinder
Eamonn J Obrien
Caroline Michie
Charlie Gourley
Laura A Hill
Katherine E Keating
Jude Odonnell
Max Bylesjo
Steve Deharo
Vitali Proutski
Richard Kennedy
Timothy Davison
Andreas Winter
Andrena Mccavigan
Original Assignee
Almac Diagnostics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Diagnostics Ltd filed Critical Almac Diagnostics Ltd
Publication of HK1214633A1 publication Critical patent/HK1214633A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Databases & Information Systems (AREA)
  • Software Systems (AREA)
  • Epidemiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
HK16102633.1A 2012-12-03 2016-03-08 癌症的分子診斷測試 HK1214633A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261732761P 2012-12-03 2012-12-03
PCT/GB2013/053202 WO2014087156A1 (en) 2012-12-03 2013-12-03 Molecular diagnostic test for cancer

Publications (1)

Publication Number Publication Date
HK1214633A1 true HK1214633A1 (zh) 2016-07-29

Family

ID=49780086

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102633.1A HK1214633A1 (zh) 2012-12-03 2016-03-08 癌症的分子診斷測試

Country Status (12)

Country Link
US (1) US11091809B2 (zh)
EP (1) EP2925885B1 (zh)
JP (1) JP2015536667A (zh)
KR (1) KR20150090246A (zh)
CN (1) CN105102631A (zh)
AU (1) AU2013353839A1 (zh)
CA (1) CA2893033A1 (zh)
HK (1) HK1214633A1 (zh)
IL (1) IL239196A0 (zh)
MX (1) MX2015006955A (zh)
SG (1) SG11201504023SA (zh)
WO (1) WO2014087156A1 (zh)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2715348B1 (en) 2011-06-02 2019-04-10 Almac Diagnostic Services Limited Molecular diagnostic test for cancer
WO2014087156A1 (en) 2012-12-03 2014-06-12 Almac Diagnostics Limited Molecular diagnostic test for cancer
US10456470B2 (en) 2013-08-30 2019-10-29 Genentech, Inc. Diagnostic methods and compositions for treatment of glioblastoma
US10617755B2 (en) 2013-08-30 2020-04-14 Genentech, Inc. Combination therapy for the treatment of glioblastoma
GB201409479D0 (en) * 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular diagnostic test for cancer
GB201409476D0 (en) * 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular subtype for use in prognosis
GB201409478D0 (en) * 2014-05-28 2014-07-09 Almac Diagnostics Ltd Pro-angiogenic signature
WO2016011052A1 (en) * 2014-07-14 2016-01-21 Genentech, Inc. Diagnostic methods and compositions for treatment of glioblastoma
CN104212440B (zh) * 2014-09-03 2016-03-30 无锡艾德美特生物科技有限公司 一类喹唑啉类荧光探针及其制备和应用
KR20170094165A (ko) * 2014-12-23 2017-08-17 제넨테크, 인크. 화학요법-내성 암을 치료 및 진단하는 조성물 및 방법
CN108496084B (zh) * 2016-01-25 2021-11-05 赛诺菲 通过测量血浆生物标记的水平预测疑似患有癌症的患者使用阿柏西普的治疗的结果的方法
CA3020718A1 (en) * 2016-04-15 2017-10-19 Genentech, Inc. Methods for monitoring and treating cancer
KR20190007026A (ko) * 2016-05-17 2019-01-21 제넨테크, 인크. 면역요법에서의 진단 및 사용을 위한 기질 유전자 특질
JP6899848B2 (ja) 2016-12-28 2021-07-07 公益財団法人がん研究会 抗ｖｅｇｆｒ−２抗体医薬品の治療効果を予測するバイオマーカー、検査方法、及び検査キット
KR20190134631A (ko) 2017-03-01 2019-12-04 제넨테크, 인크. 암의 진단 및 치료 방법
US10720230B2 (en) * 2017-06-13 2020-07-21 Bostongene Corporation Method for administering a checkpoint blockade therapy to a subject
US10636512B2 (en) * 2017-07-14 2020-04-28 Cofactor Genomics, Inc. Immuno-oncology applications using next generation sequencing
WO2019014647A1 (en) * 2017-07-14 2019-01-17 Cofactor Genomics, Inc. IMMUNO-ONCOLOGIC APPLICATIONS USING NEXT GENERATION SEQUENCING
CN107621545B (zh) * 2017-07-26 2019-10-11 东南大学 Bicc1蛋白对精神疾病诊断的新用途
WO2019074920A1 (en) * 2017-10-10 2019-04-18 Oncocyte Corporation METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF BREAST CANCER
US20200294622A1 (en) * 2017-12-04 2020-09-17 Nantomics, Llc Subtyping of TNBC And Methods
CN108524937B (zh) * 2018-05-11 2020-05-05 中南大学湘雅三医院 Mrvi1-as1作为靶位点在制备治疗鼻咽癌紫杉醇化疗增敏药物中的应用
EP3843638A4 (en) * 2018-08-31 2022-05-18 Seno Medical Instruments, Inc. METHODS AND SYSTEMS FOR DETERMINING MOLECULAR CANCER SUBTYPES BASED ON ULTRASOUND AND/OR OPTOACOUSTIC (OA/US) PROPERTIES
CN109585011A (zh) * 2018-10-26 2019-04-05 朱海燕 胸痛患者的病症诊断方法及机器可读存储介质
CN110358827A (zh) * 2019-07-09 2019-10-22 中国人民解放军第四军医大学 Vmp1基因在病理诊断胶质母细胞瘤中的应用及其试剂盒的制备
WO2021034091A1 (ko) * 2019-08-19 2021-02-25 재단법인 아산사회복지재단 교모세포종의 진단 방법
IT201900023946A1 (it) * 2019-12-13 2021-06-13 Complexdata S R L Metodo per determinare una prognosi di sopravvivenza a lungo termine di pazienti di cancro al seno, sulla base di algoritmi che modellizzano reti biologiche
CN111105843B (zh) * 2019-12-31 2023-07-21 杭州纽安津生物科技有限公司 一种hlai型分子与多肽的亲和力预测方法
CN111735949B (zh) * 2020-07-17 2023-07-21 北京信诺卫康科技有限公司 Wnt7a和CA125联合用作早期卵巢癌生物标志物以及试剂盒
CN112266961B (zh) * 2020-10-29 2023-05-12 中山大学附属第六医院 Tsg-6基因在预测结直肠癌转移及预后方面的应用
CN112592397B (zh) * 2020-12-31 2022-08-30 上海市胸科医院 Ccdc80来源的多肽及其用途
CN113035298B (zh) * 2021-04-02 2023-06-20 南京信息工程大学 递归生成大阶数行限制覆盖阵列的药物临床试验设计方法
KR20220141216A (ko) * 2021-04-12 2022-10-19 연세대학교 산학협력단 유방암 진단을 위한 신규 바이오마커
WO2022241264A2 (en) * 2021-05-13 2022-11-17 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of targeted multi-panel approach and tiered a.i. use for differential diagnosis and prognosis
CN116482367A (zh) * 2023-05-04 2023-07-25 中国中医科学院望京医院(中国中医科学院骨伤科研究所) 一种联合mSEPT9检测和生物标志物的结直肠癌检测方法
CN116519954B (zh) * 2023-06-28 2023-10-27 杭州广科安德生物科技有限公司 一种结直肠癌检测模型构建方法、系统及生物标志物
CN117089621B (zh) * 2023-09-28 2024-06-25 上海爱谱蒂康生物科技有限公司 生物标志物组合及其在预测结直肠癌疗效中的应用

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
EP0430881A3 (en) 1989-11-29 1991-10-23 Ciba-Geigy Ag Photochromic compounds, process for their preparation and their use
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
EP0636186B1 (en) 1992-04-03 1998-11-25 The Perkin-Elmer Corporation Probe composition and method
US5503980A (en) 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5470710A (en) 1993-10-22 1995-11-28 University Of Utah Automated hybridization/imaging device for fluorescent multiplex DNA sequencing
GB9401833D0 (en) 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
US6946442B2 (en) 1994-11-30 2005-09-20 Asif Syed Ahmed Method of hastening cervical ripening
GB9507238D0 (en) 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
US5661028A (en) 1995-09-29 1997-08-26 Lockheed Martin Energy Systems, Inc. Large scale DNA microsequencing device
AU2253397A (en) 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
US6680175B2 (en) 1998-05-05 2004-01-20 Adherex Technologies, Inc. Methods for diagnosing and evaluating cancer
WO2004005883A2 (en) 2002-07-02 2004-01-15 The Johns Hopkins University Secreted and cytoplasmic tumor endothelial markers
US6998234B2 (en) 2000-11-03 2006-02-14 Oncotech, Inc. Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells
AU2003234613A1 (en) 2002-05-15 2003-12-02 Seul, Kyung, Hwan Method of modulating angiogenesis
EP2248829A1 (en) 2003-05-30 2010-11-10 Genentech, Inc. Treatment with anti-VEGF antibodies
WO2004108896A2 (en) 2003-06-03 2004-12-16 The Board Of Trustees Of The University Of Arkansas Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors
US7700280B2 (en) 2003-12-31 2010-04-20 The Penn State Research Foundation Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer
US20080113874A1 (en) 2004-01-23 2008-05-15 The Regents Of The University Of Colorado Gefitinib sensitivity-related gene expression and products and methods related thereto
US7871769B2 (en) 2004-04-09 2011-01-18 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
WO2005103281A2 (en) * 2004-04-26 2005-11-03 Children's Medical Center Corporation Platelet biomarkers for the detection of disease
US20080199855A1 (en) 2004-05-14 2008-08-21 Monica Nister Identification And Characterization Of A Subset of Glioblastomas Sensitive To Treatment With Imatinib
CA2574311A1 (en) 2004-07-23 2006-01-26 Astrazeneca Ab Method of predicting the responsiveness oa a tumor to erbb receptor drugs
WO2006048291A2 (en) 2004-11-03 2006-05-11 Almac Diagnostics Limited Transcriptome microarray technology and methods of using the same
US7862995B2 (en) 2004-12-10 2011-01-04 Targeted Molecular Diagnostics Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
ATE477495T1 (de) 2005-03-16 2010-08-15 Osi Pharm Inc Biologische marker prediktiv für das ansprechen von krebs auf inhibitoren der kinase des rezeptors für epidermalen wachstumsfaktor
WO2007015947A2 (en) 2005-07-29 2007-02-08 Bayer Healthcare Llc Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
ES2374450T3 (es) 2005-09-20 2012-02-16 OSI Pharmaceuticals, LLC Marcadores biológicos predictivos de respuesta anticancerígena para inhibidores de cinasa del receptor del factor de crecimiento 1 similar a insulina.
US8445198B2 (en) 2005-12-01 2013-05-21 Medical Prognosis Institute Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
WO2007067476A2 (en) 2005-12-05 2007-06-14 Merck & Co., Inc. Methods for predicting treatment response based on the expression profiles of protein and transcription biomakers
US20070128636A1 (en) 2005-12-05 2007-06-07 Baker Joffre B Predictors Of Patient Response To Treatment With EGFR Inhibitors
JP2009524438A (ja) 2006-01-27 2009-07-02 トライパス イメージング インコーポレイテッド 卵巣癌を有する可能性の高い患者を同定するための方法およびそのための組成物
CA2639070A1 (en) 2006-04-13 2007-11-01 Oncomethylime Sciences S.A. Novel tumour suppressor
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
BRPI0716944A2 (pt) 2006-09-19 2013-09-17 Novartis Ag biomarcadores de modulaÇço alvo, eficÁcia, diagnàstico, e/ou prognàstico para inibidores de raf
EP2201142A1 (en) 2007-08-13 2010-06-30 Almac Diagnostics Limited A 3' -based sequencing approach for microarray manufacture
WO2009042814A1 (en) 2007-09-25 2009-04-02 Minerva Biotechnologies Corp. Early diagnosis and treatment of drug resistance in muc1-positive cancer
NZ562237A (en) 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
US20090123930A1 (en) * 2007-11-09 2009-05-14 Wu Thomas D Methods and compositions for diagnostic use in cancer patients
EP2242852A4 (en) * 2007-12-07 2011-02-09 Univ Oregon Health & Science PROCEDURE FOR DETERMINING WHETHER AN INDIVIDUAL REQUIRES A BCR ABL INHIBITOR
US8507656B2 (en) * 2008-01-28 2013-08-13 Medimmune Limited Stabilized angiopoietin-2 antibodies and uses thereof
US8114593B2 (en) 2008-03-12 2012-02-14 University Of Medicine And Dentistry Of New Jersey Cancer biomarker genes and gene products and methods for using the same
EP2297349A1 (en) 2008-06-04 2011-03-23 The Arizona Board Of Regents On Behalf Of The University Of Arizona Diffuse large b-cell lymphoma markers and uses therefor
CA2726811C (en) 2008-06-06 2019-11-26 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Survival predictor for diffuse large b cell lymphoma
CN102159727A (zh) 2008-07-16 2011-08-17 达纳-法伯癌症研究院有限公司 与前列腺癌有关的信号和胆碱磷酸决定子以及它们的使用方法
WO2010010153A1 (en) 2008-07-23 2010-01-28 F. Hoffmann-La Roche Ag Identification of subjects being susceptible to anti-angiogenesis therapy
CN102265156B (zh) 2008-12-23 2014-11-05 默克专利有限公司 用于具有抗血管发生活性的抑制剂的生物标志
WO2010088688A2 (en) 2009-02-02 2010-08-05 Biotheranostics, Inc. Diagnosis of in situ and invasive breast cancer
WO2010127322A1 (en) 2009-05-01 2010-11-04 Genomic Health Inc. Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
US7615353B1 (en) * 2009-07-06 2009-11-10 Aveo Pharmaceuticals, Inc. Tivozanib response prediction
BR112012005670A2 (pt) 2009-09-17 2017-01-10 Hoffmann La Roche ''método para a identificação de um paciente com câncer que pode se beneficiar com a terapia antiagiogênica, método para a predição da responsividade de um paciente com câncer à terapia antiangiogênica, uso de um anticorpo anto- vegf para melhorar o efeito do tratamento de um paciente sofrendo de câncer, método ou uso, kit útil para realizar o método, uso de uma proteína ou usom kit útil para realizar o método, uso de uma proteína ou oligonucleotídeo ou matriz de polinecleotídeo para determinar o nível de expressão de bfgf em um método e kit ou uso
EA201390370A1 (ru) 2010-09-15 2013-07-30 Олмак Дайэгностикс Лимитед Молекулярно-диагностический тест для определения онкологического заболевания
WO2012054284A2 (en) * 2010-10-20 2012-04-26 University Of Tennessee Research Foundation Interferon gene signature and methods of use thereof
WO2012052757A1 (en) 2010-10-20 2012-04-26 Astrazeneca Ab Tumour phenotype patient selection method
WO2012092336A2 (en) 2010-12-28 2012-07-05 Caris Mpi, Inc. Molecular profiling for cancer
EP2715348B1 (en) 2011-06-02 2019-04-10 Almac Diagnostic Services Limited Molecular diagnostic test for cancer
KR20140114415A (ko) 2012-01-13 2014-09-26 제넨테크, 인크. Vegf 길항제로의 치료를 위한 환자를 확인하기 위한 생물학적 마커
EP2667193A1 (en) 2012-05-23 2013-11-27 Université d'Aix-Marseille MMP2 as a predictive biomarker of response to antiangiogenic therapy and survival after therapy in cancer patients
WO2014087156A1 (en) 2012-12-03 2014-06-12 Almac Diagnostics Limited Molecular diagnostic test for cancer

Also Published As

Publication number Publication date
US20160002732A1 (en) 2016-01-07
KR20150090246A (ko) 2015-08-05
CN105102631A (zh) 2015-11-25
CA2893033A1 (en) 2014-06-12
US11091809B2 (en) 2021-08-17
EP2925885A1 (en) 2015-10-07
SG11201504023SA (en) 2015-06-29
JP2015536667A (ja) 2015-12-24
EP2925885B1 (en) 2020-02-05
WO2014087156A1 (en) 2014-06-12
MX2015006955A (es) 2016-01-25
IL239196A0 (en) 2015-07-30
AU2013353839A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
HK1214633A1 (zh) 癌症的分子診斷測試
ZA201508689B (en) Molecular diagnostic test for cancer
IL229681A0 (en) A molecular diagnostic test for cancer
HK1245888A1 (zh) 對癌症的代理功能性診斷測試
IL244472A0 (en) Molecular diagnostic test for lung cancer
HRP20181576T1 (hr) Blok za dijagnosticiranje transakcije
IL244471A0 (en) Molecular diagnostic test for esophageal cancer
EP2699144A4 (en) STUDY INSTRUMENT
SG2013079553A (en) Rf testing system
GB2518081B (en) Providing an ID-verified blood test
GB2507283B (en) Probe
EP2524702A4 (en) DIAGNOSTIC TO CANCER
EP2870499A4 (en) DIAGNOSTIC DEVICE
EP2832302A4 (en) PROBE
GB201012590D0 (en) Methods for diagnosing cancer
SG11201502499UA (en) Cancer diagnosis device
EP2742358A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
HK1200723A1 (zh) 藥學診斷
GB2505193B (en) Probe
EP2826412A4 (en) PROBE
EP2870998A4 (en) TEST TUBE
AP2013008332A0 (en) Diagnostic probe
TWI560452B (en) Probe card for circuit-testing
HU4255U (en) Diagnostic device for sole-pressure distribution
TWI560451B (en) Probe card for circuit-testing